MDWerks Inc.

Director

• Mineralys Therapeutics is a clinical-stage biotechnology company developing lorundrostat, an aldosterone synthase inhibitor for cardiorenal conditions
• Lead creation of a data-driven value proposition tailored to payer and policy stakeholders
• Collaborate with Medical Affairs, HEOR, and Clinical teams to align messaging with product profile and unmet need
• Develop payer-facing materials including AMCP dossiers, PIE, and value decks
• Identify evidence gaps and prioritize evidence needs to support access and reimbursement goals
• Partner with HEOR and RWE teams to guide development of economic models, burden-of-illness studies, and comparative effectiveness research
• Develop pricing scenarios and recommendations and design innovative contracting approaches including value-based agreements
• Serve as the internal market access lead for the cardiovascular launch team and provide strategic input to Commercial, Medical, Regulatory, and Finance teams
• Monitor reimbursement policies, HTA trends, and payer expectations and translate external insights into actionable internal strategies

Director, Market Access